AuntMinnie

MARCH 25, 2024

Coronary artery disease (CAD) is the leading cause of mortality in the U.S. In a cohort of 1,282 patients who underwent invasive coronary angiography for suspected disease, noninvasive PET MPI performed within six months identified large perfusion defects (>10% of the left ventricular myocardium) in 82% of the patients.

Nuclear Medicine 321

Nuclear Medicine Radiopharmaceuticals Disease Imaging 321

Open Medscience

MARCH 22, 2024

Nuclear medicine and the future of precise, personalised care in diagnosing and treating diseases. The post Nuclear Medicine at the Centre of Radiology and Radiopharmaceuticals appeared first on Open Medscience.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiology Disease 52

AuntMinnie

SEPTEMBER 25, 2024

Nuclear cardiologists could see significant reductions in Medicare reimbursements in 2025, according to a leading expert. million coronary artery disease procedures per year. Phillips, current president of the American Society for Nuclear Cardiology (ASNC), said that the organization has not spoken out against the unbundling process.

Radiopharmaceuticals 162

Radiopharmaceuticals Nuclear Medicine Medicare Diagnostic 162

AuntMinnie

JULY 10, 2024

Centers for Medicare and Medicaid Services (CMS) proposed a new reimbursement plan July 10 for diagnostic PET scans that would provide separate payments for radiopharmaceuticals, as well as an extra payment for hospitals when they use domestically produced technetium-99m (Tc-99m).

Medicare 130

Medicare Nuclear Medicine Radiopharmaceuticals Imaging 130

AuntMinnie

JANUARY 19, 2024

more than 6 million Americans have Alzheimer's disease, a debilitating and far-reaching disease that accounts for 60% to 80% of dementia cases, and by 2050, this number is projected to rise to nearly 13 million, according to Alzheimer’s Disease International. The disease affects memory, thinking, and behavior. In the U.S.,

Disease 130

Disease Medicare Imaging PET Scan 130

AuntMinnie

JUNE 10, 2024

A new AI PET/CT tool can assess patient cancer risk, predict tumor response, and estimate survival, according to research findings delivered June 10 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Toronto.

Nuclear Medicine 257

Nuclear Medicine Radiopharmaceuticals Imaging Medical Imaging 257

Imaging Technology

JUNE 10, 2024

Anderson , PhD, a trailblazer in nuclear medicine, has been named the 2024 recipient of the Georg Charles de Hevesy Nuclear Pioneer Award. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2024 Annual Meeting, June 8-11 in Toronto.

Nuclear Medicine 104

Nuclear Medicine Radiopharmaceuticals Disease Imaging 104

Imaging Technology

JANUARY 5, 2024

This leading radiopharmaceutical platform provides detailed PET imaging-based diagnosis and dosimetry using long-lived copper-64 ( 64 Cu) for imaging and alpha-particle targeted RPT using lead-212 ( 212 Pb). milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

Radiopharmaceuticals 104

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 104

AuntMinnie

JULY 29, 2024

In addition, the proposal includes a nuclear health center for processing medical isotopes produced by the reactor into radiochemicals, which will then be further processed into radiopharmaceuticals that can be administered to patients for the diagnosis and treatment of several diseases, including cancer, the commission said.

Medical 130

Medical Nuclear Medicine Radiopharmaceuticals Disease 130

Future Teleradiology

NOVEMBER 27, 2023

Teleradiology-India Introduction: Nuclear medicine continues to be at the forefront of cutting-edge technologies, pushing the boundaries of diagnostic and therapeutic capabilities. Revolutionary Radioisotopes: Expanding the Diagnostic Toolkit: Explore the latest developments in novel radioisotopes used in nuclear medicine.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Imaging Modalities Radiation 52

AuntMinnie

OCTOBER 2, 2024

Ultrasound model predicts liver disease progression. Bodien, et al, New England Journal of Medicine , August 14, 2024. Commercially Available Chest Radiograph AI Tools for Detecting Airspace Disease, Pneumothorax, and Pleural Effusion. Luthria, et al, Journal of Nuclear Medicine , October 26, 2023.

Digital Imaging and Communications in Medicine 360

Digital Imaging and Communications in Medicine X-ray MRI Hospital 360

Future Teleradiology

NOVEMBER 21, 2023

Teleradiology & Radiology data for artificial intelligence (AI) Introduction: Nuclear medicine, a dynamic and rapidly evolving field, continues to break new ground in diagnostic and therapeutic approaches. Introduction to Nuclear Medicine: Merging Physics and Medicine: Provide an overview of nuclear medicine.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Teleradiology 52

Imaging Technology

JUNE 26, 2023

Mahmood was presented the award by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) at its 2023 Annual Meeting. Award recipients will have initiated, developed, and successfully implemented unique and significant transformative value within the field of nuclear medicine and molecular imaging.

Nuclear Medicine 98

Nuclear Medicine Education Radiopharmaceuticals Hospital 98

Open Medscience

AUGUST 11, 2024

Radiopharmaceuticals in diagnostics provide critical insights into disease processes, improving accuracy, patient care, and treatment outcomes significantly. The post The Transformative Power of Radiopharmaceuticals in Diagnostics appeared first on Open MedScience.

Radiopharmaceuticals 52

Radiopharmaceuticals Diagnostic Patient Care Disease 52

Imaging Technology

JUNE 19, 2023

milla1cf Mon, 06/19/2023 - 19:27 June 19, 2023 — NorthStar Medical Technologies, LLC , a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Frank Scholz, Ph.D., NorthStar’s commercialized, U.S.-based

Medical 98

Medical Pharmaceutical Radiopharmaceuticals Nuclear Medicine 98

AuntMinnie

NOVEMBER 12, 2024

Middlebrooks' research interest consists of using ultrahigh-field, 7-tesla MRI to plot brain microstructure and develop surgical treatment of brain tumors, epilepsy, and neurodegenerative and movement disorders such as Parkinson's disease, essential tremor, and dystonia. from Ukraine.

Radiologist 360

Radiologist Education Clinic Radiology 360

Imaging Technology

APRIL 5, 2024

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

Imaging Technology

JUNE 29, 2023

milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 98

Clinic Nuclear Medicine Radiopharmaceuticals Radiation 98

Imaging Technology

APRIL 3, 2023

Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit. Ac-225 using advanced, environmentally preferable electron accelerator technology.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

Open Medscience

NOVEMBER 9, 2023

Alzheimer's disease stems from genetic mutations and lifestyle factors, leading to brain plaque accumulation and dementia. The post Unveiling the Complex Etiology and Innovative Diagnostic Approaches in Alzheimer’s Disease appeared first on Open Medscience.

Disease 59

Disease Diagnostic Nuclear Medicine Radiopharmaceuticals 59

Imaging Technology

JUNE 20, 2024

For the practice of precision care in molecular imaging and nuclear medicine, this begins with the production of radioisotopes for use in diagnostic tracers, which are administered to patients, attach to specific biomarkers, and release radioactive emissions to provide clinicians detailed molecular information unique to each patient.

Healthcare 104

Healthcare Healthcare Nuclear Medicine Computed Tomography 104

TRA Medical Imaging

JANUARY 17, 2025

Neuroradiology: Neuroradiologists focus on conditions of the brain, spine, and nervous system, using advanced techniques like MRI and CT to diagnose strokes, tumors, and degenerative diseases. Interventional Radiology (IR): This sub-specialty focuses on minimally invasive procedures guided by imaging.

Radiologist 52

Radiologist Nuclear Medicine Minimally Invasive Procedure IT 52

Imaging Technology

JANUARY 30, 2025

30, 2025 Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,

Nuclear Medicine 52

Nuclear Medicine Imaging Patient Care Disease 52

Imaging Technology

OCTOBER 4, 2024

As Theranostics and the use of radiopharmaceutical therapy (RPT) to treat cancer and other diseases have become more prevalent, interest in using dosimetry to personalize RPT treatments has grown. Dosimetry in Radiopharmaceutical Therapy. J Nucl Med. 2022 Oct;63(10):1467-1474. doi: 10.2967/jnumed.121.262305. 121.262305. [ii]

Radiopharmaceuticals 52

Radiopharmaceuticals Nuclear Medicine Radiation Healthcare 52

Imaging Technology

NOVEMBER 1, 2024

Front loading radioactivity and extending the time on therapy may lengthen time to disease progression. Dosimetry of [ 177 Lu] Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comprehensive Systematic Review and Meta analysis." Journal of Nuclear Medicine (2024). 1 Ells, Zachary, et al.

Nuclear Medicine 52

Nuclear Medicine Radiation Radiopharmaceuticals Clinic 52

Open Medscience

AUGUST 11, 2024

Pittsburgh Compound-B allows researchers to visualise amyloid plaques in the brain, aiding in Alzheimer's disease diagnosis and study. The post The Discovery and Development of Pittsburgh Compound-B (PIB): A Breakthrough in Alzheimer’s Disease Research appeared first on Open MedScience.

Disease 40

Disease Nuclear Medicine Radiopharmaceuticals Imaging 40

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 306

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 306

Open Medscience

JANUARY 28, 2024

PET imaging dramatically enhances early disease detection, significantly improving patient outcomes in various medical fields. The post PET Imaging and Its Transformative Impact in Modern Medicine appeared first on Open Medscience.

IT 52

IT Imaging Disease Medical 52

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 130

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 130

AuntMinnie

JANUARY 8, 2025

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released new appropriate use criteria for brain PET imaging of amyloid and tau pathology related to cognitive impairment and Alzheimers disease. There are three PET radiotracers labeled with F-18 approved by the U.S.

Nuclear Medicine 290

Nuclear Medicine Imaging Radiopharmaceuticals Medicare 290

AuntMinnie

NOVEMBER 21, 2024

It's only been a few years since a dedicated track in nuclear medicine and molecular imaging was established at the meeting, and the practice already dominates it. All studies in the sole slated session on novel radiopharmaceuticals this year are on FAPI-PET tracers. Below is just a sample of the content on offer. 8:40 a.m. |

Imaging 264

Imaging Nuclear Medicine Radiopharmaceuticals Disease 264

Imaging Technology

JANUARY 14, 2025

8, 2025 The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Tue, 01/14/2025 - 16:48 Jan.8,

Nuclear Medicine 52

Nuclear Medicine Imaging Patient Care PET Scan 52

Global Radiology CME

DECEMBER 21, 2024

A nuclear medicine hepatobiliary scan was also performed (not shown) and demonstrated no radiopharmaceutical present in the gallbladder due to cystic duct obstruction. Interventional approaches to gallbladder disease. A transperitoneal route is favored in patients with coagulopathy or diffuse liver disease [1].

Education 52

Education Global Radiology Nuclear Medicine Ultrasound 52